Lung infections due to Burkholderia cepacia and Pseudomonas aeruginosa in patients with cystic fibrosis (CF) are common, are associated with respiratory morbidity and are a cause of mortality. Respiratory mucin in CF patients is highly sulphated, which increases its resistance to bacterial degradation. Desulphation increases the susceptibility of mucin to degradation by bacterial glycosidases and proteinases, and subsequent deglycosylation may facilitate bacterial colonisation by increasing available substrates and binding sites. This study determined whether clinical and environmental strains of B. cepacia and I! aeruginosa had the ability to desulphate mucin. Mucin-sulphatase activity was tested by incubating bacterial cell suspensions with 35S-sulphated mucins purified from LSl74T and HT29-MTX human colon carcinoma cell lines. These mucins were also used to test for differences in substrate specificities. Mucin-sulphatase activity was detected in all nine B. cepacia strains and in four of six I! aeruginosa strains. There was strain variability in the level of mucin-sulphatase activity. Aryl-sulphatase activities of Pseudomonas isolates (determined with methylumbelliferyl sulphate) were c. 20-fold higher than those of B. cepacia strains, and were independent of mucin-sulphatase activity. This is the first report to demonstrate desulphation of mucin by B. cepacia and I! aeruginosa. It is concluded that B. cepacia and I! aeruginosa produce one or more cell-bound glycosulphatase(s), in addition to aryl-sulphatase activity. Mucin-sulphatase activity of B. cepacia and I! aeruginosa may contribute to their association with airway infections in patients with cystic fibrosis.
Introduction
Burkholderia cepacia and Pseudomonas aeruginosa are opportunist pathogens that frequently colonise the respiratory tract of patients whose mucociliary clearance is defective [l, 21. The most striking of such diseases is cystic fibrosis (CF). CF is characterised by production of a highly viscid respiratory mucin which results in impaired mucociliary clearance, generalised mucus obstruction and colonisation of the airways by I? aeruginosa . The initial colonisation is with non-mucoid I? aeruginosa, but mucoid variants emerge later and are associated with chronic pulmonary infection [ 11. The reasons why these organisms colonise and persist in the respiratory tract are not fully understood. Although the prevalence of B. cepacia (7%) [2] is not as high as that of 19 aeruginosa (77%) [3] , it is increasing and epidemic spread of highly transmissible strains has been reported [4, 51. The clinical course of B. cepacia infection is variable, but c. 20% of patients succumb to the so-called 'cepacia syndrome', a rapidly fatal clinical deterioration with necrotising pneumonia and bacteraemia [2] .
The severity of CF correlates with increased acidity of tracheo-bronchial mucin from such patients [6] . Part of the increased acidity is caused by mucin oversulphation [7, 81 , possibly due to perturbations in intracellular sulphate activation or the transfer of activated sulphate to the mucin molecule [9] , and part is the result of degradation of neutral mucin oligosaccharides by I? aeruginosa [ lo] . The sulphate esters impart a strong negative charge, which influences the physical properties of the mucus [ll] .
Sulphate is thereby likely to contribute significantly to the rheological properties of CF mucin. The increased tenacity of CF mucins impedes mucociliary clearance. Host defence at the epithelial surface is decreased by a raised NaCl concentration as a result of cystic fibrosis transmembrane regulator (CTFR)-associated defective C1-transport across the airway epithelia [ 121. Hampered mucus clearance and decreased host defence both strongly favour bacterial colonisation, but only if bacteria can find sufficient substrates to metabolise and sites for adherence.
In general, mucin is most heavily sulphated at bodily sites such as the mouth and the colon where there is a rich normal flora [13] . This sulphation protects the mucin from bacterial degradation unless the bacteria also have mucin-sulphatase activity [ 141. Desulphation increases the susceptibility of mucin to breakdown by bacterial glycosidases and proteinases as it exposes formerly inaccessible oligosaccharides and, ultimately, the protein core [ 131. The released carbohydrates and amino acids are likely to stimulate bacterial growth by analogy with mucin degradation by consortia of oral [15, 161 cepacia have been reported to recognise and adhere to di-and tri-saccharide structures that are part of mucin side chains [26-281. However, these antigenic structures may be shielded by other carbohydrate residues, sialic acid, or sulphate, and thus are not readily available for adhesion. Partial deglycosylation of mucin, of which desulphation is thought to be a first step, may promote bacterial colonisation by increasing available substrate and exposing cryptic binding sites.
In this study, clinical and environmental strains of B. cepacia and I? aeruginosa were investigated to determine the prevalence of mucin-sulphatase activity among these two respiratory pathogens.
Materials and methods

Bacterial strains
Non-mucoid strains of B. cepacia and I? aeruginosa (Table 1) were obtained from the collection of the Department of Medical Microbiology, University of Liverpool and comprised mostly isolates from previous studies [3, 29, 30] . All strains were identified by standard biochemical techniques and the API 20 NE system (bioMerieux) and confirmed by the Central Public Health Laboratory (6 1 Colindale Avenue, London). Environmental strains of B. cepacia were described further by Butler et al. [29] . B. cepacia epidemic isolates were from different patients from different centres and confirmed to be separate strains by SDS-PAGE of spectroscopy [30] .
Bacterial growth
whole protein and pyrolysis mass conditions Strains of B. cepacia and I? aeruginosa and the arylsulphatase negative control strain Escherichia coli K12 that were tested for aryl-sulphatase activity and sulphatase activity against LS174T mucin were grown in triplicate on blood agar containing defibrinated horse blood 5% v/v, for 24 h at 37"C, harvested with sterile swabs, washed once in 0.1 M Tris, 0.15 M NaCl, pH 7.0 (Tris-saline) and resuspended in 5 ml of Tris-saline. Strains of B. cepacia that were tested for sulphatase activity against HT29-MTX mucin were grown on five plates of blood agar for 24 h at 37°C. Mucin-sulphatase positive control strain Bacteroides thetaiotaomicron NCTC 10582 was grown anaerobically on 10 plates of blood agar for 48 h. The protein content of bacterial cell suspensions was estimated by the biuret bicinchoninic acid (BCA) protein assay (Sigma) with bovine serum albumin as a standard.
Mucin 35 SO3-labelled human colonic mucin was obtained after incorporation of 35 S042-into mucins secreted by 35 S-labelled-sulphated mucins were purified from cells and cell culture medium by gel filtration on Sepharose CL-4B (Pharmacia) and Superose-6 FPLC (Pharmacia) as described previously [32] . Mucin-containing fractions were pooled, lyophilised and de-salted on prepacked gravity-fed PD 1 0-Sephadex G25M columns (5 X 1.5 cm; Pharmacia) equilibrated in 0.1 M Tris-HCl, pH 7.0.
Mucin-sulphatase assay
Mucin-sulphatase (MS) activity was measured by the release of 35 S042-after incubation of bacterial cells from replicate cultures of B. cepacia, R aeruginosa and E. coli with 35S-sulphated mucin by a method slightly modified from that previously described by Smalley et al. [33] . Samples of bacterial cell suspensions containing c. 1 mg of whole-cell protein were incubated at 37°C with 11 000 dpm (0,005 pCi) of 35S04-labelled mucin in a final volume of 2.5 ml of 0.1 M Tris, pH 7.0. Incubation was stopped after 48 h by boiling for 3 min. Bacterial cells were centrifuged and the supernate was passed through PD 1 0-Sephadex G25M columns (5 X 1.5 cm). The much substrate eluted in the void volume (3.5 ml) whilst cleaved 35S042-was washed from the column with a further 6 ml of Tris buffer and precipitated by addition of 1 ml of 0.1 M BaC12 and 0.9 ml of 0.1 M This method precipitates free sulphate but not sulphated monosaccharides [34] . The precipitate was washed once, resuspended in 0.5 ml of Tris buffer, and radioactivity was quantified by B-scintillation counting. Bact. thetaiotaomicron [ 141 and a faecal homogenate, prepared from pooled faeces from six patients with ulcerative colitis [34] , served as positive controls (n = 8); 13 samples of 35S-sulphated mucin in Tris buffer were used as negative controls to assess spontaneous background hydrolysis of sulphate. was stopped after 24 h by boiling for 3 min, cellular debris was centrifuged and the volume adjusted to 3 ml with 2.2 mM NaOH to a h a 1 pH of 10.3 (the pH optimum of fluorescence intensity of MUF [35] ). The amount of released sulphate was calculated from the concentration of free MUF as detected with a Model 1 000 Fluorescence Spectrophotometer (excitation 363 11111, emission 450 nm; Perkin Elmer). Free MUF (Sigma) was used as a standard. Strains of l? aeruginosa [36] and faecal homogenate from patients with ulcerative colitis were used as positive controls; E. coli K12 and Tris buffer were negative controls. Suspensions of bacterial cells in Tris buffer served to control for autofluorescence of bacterial products.
Aryl-sulphatase assay
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The data are expressed as means and SEM and amounts of sulphate released by bacterial strains were compared with that released by the Tris buffer control. Differences were analysed by the one-tailed Student's t test and differences at p<O.O5 were considered to be significant.
Results
With an assay in which 35S042-was cleaved from 35Slabelled human colonic mucin and precipitated with BaC12, mucin-sulphatase activity was shown to be associated with whole cells of B. cepacia and R aeruginosa clinical and environmental isolates. All isolates of B. cepacia possessed MS activity against one or both 35S-mucins ( Fig. 1 ). Four of nine isolates were active against either LS 174T or HT29-MTX mucin; the other five isolates were active against both. Sulphatase activity against LS 174T-derived mucin was detected in four of the six l? aeruginosa isolates. Interstrain MS activity of the test isolates varied, but MS activity was usually similar to or greater than that displayed by the positive control, Bact. thetaiotaomicron. Of the MS-positive isolates, the average release of radioactivity minus that of the Tris negative control for B. cepacia, as a percentage of the total available, was 2.8% SD 3.0% (n = 7, range 0.5-9%) for LS174T mucin and 4.3% SD 2.6% (n = 7, range 2-10%) for HT29-MTX mucin. The average sulphatase desulphation of LS174T mucin by I! aeruginosa (2.5%SD 0.7, n = 4) was similar to that of B. cepacia, but the range of interstrain MS activity was smaller (2-3.5%). The faecal homogenate liberated 3 8% of radiolabelled sulphate from LS174T mucin, but only 5.5% from HT29-MTX mucin. Clinical isolates of B. cepacia did not appear to have MS activities different from those of environmental strains, as was the case for epidemic versus nonepidemic isolates. Furthermore, sulphatase activity against LS174T-derived mucin was detected in E. coli.
AS activity was demonstrated in all isolates of B. cepacia and R aeruginosa (Fig. 2) ~I , I~I~~~I I I I I I~I I I~I I I I I I I I I I~I I I I~~I I I I I I I thetaiotaomicron and the (AS-negative) E. coli control strain did not correlate with the presence of MS activity, indicating that the activities are mediated by different enzymes. As suspensions of washed bacterial cells were used, the mucin-and aryl-sulphatases detected are likely to be cell-wall-associated or localised in the periplasmic space.
Discussion
This study demonstrated for the first time that B. cepacia and I? aeruginosa can desulphate mucin. MS activity with I? aeruginosa has not been reported previously and is mediated by an enzyme that differs from the aryl- [36] , choline- [37] and alkyl- [38] sulphatase activities that have been known for some time. No sulphatase activity of any kind has been demonstrated before in B. cepacia. The present study further indicates that, although the level of MS activity may vary considerably between isolates, this ability is found commonly in the two genera and they are relatively active as compared with control organisms from the gut such as Bact. thetaiotaomicron and E. coli.
The role of sulphomucins and the importance of mucin desulphation in the gut was reviewed recently [ 131. In colonic mucin, sulphate is ester-linked to C-3 and C-6 of galactose and N-acetylglucosamine residues [19, 39] . As sulphate is found on the same positions and residues in human tracheobronchial and CF-derived mucin it seems likely that the sulphatases detected in B. cepacia and I? aeruginosa can also degrade mucin from these sources.
To ensure a maximum release of sulphate from the substrate, an excess of the bacterial suspension in relation to available substrate was used in both MS and AS assays and incubation times were relatively long compared with other studies [33, 34, 40] . Hence, sulphatase activity is expressed as the release of absolute amounts of sulphate, rather than release of sulphate/mg of cell protein, or release of sulphate/ mg/min. Approximately 38% of radiolabelled sulphate was released from the LS174T mucin by the faecal homogenate. This is similar to the 30% of sulphate released by the faecal homogenate from mucin from cultured human colonic biopsies [34] and the 33% of sulphate released from rat gastric mucin by a purified glycosulphatase from Prevotella sp. RS2 [4 11 . However, the sulphate release from HT29-MTX mucin by the faecal homogenate was seven-fold lower, suggesting that there is substrate heterogeneity. The differences in sulphatase activity between test isolates and controls observed for mucins from the two cell lines also indicate substrate heterogeneity. This implies that mucin secreted by the LS174T cell line contains different sulphated oligosaccharide structures from mucin produced by the HT29-MTX cell line. Unfortunately, biochemical data to characterise these differences are not yet available. However, LS174T produces a mucin with the protein core (apomucin) predominantly encoded by the MUC2 gene [42] , whilst the majority of apomucins secreted by HT29-MTX are encoded by MUCSAIC and MUCSB [43] , and mucin glycosylation is modulated by the aminoacid sequence of the protein core [44] . Lower sulphate release from HT29-MTX mucin by faecal homogenate may be due to the substrate specificity of the glycosulphatases not matching the remaining sulphated sugars in the mucin oligosaccharide chains.
I! aeruginosa has few glycosidase activities [45] , but no data are available for B. cepacia. In colonic mucins, the oligosaccharide side chains are densely packed and may vary in length from 2 to 12 residues and sulphate is linked to galactose and N-acetylglucosamine along the chains [46] . The low sulphate release by bacterial samples is presumably due to steric hindrance of the neighbouring oligosaccharide side chains impeding the access of glycosulphatases to the carbohydrate side chains in the absence of bacterial glycosidases, particularly when sulphate is linked to carbohydrate residues within the side chain, or to non-matching substrate specificities of the glycosulphatases.
The B. cepacia and I? aeruginosa mucin-and arylsulphatases detected are likely to be localised either on the cell wall or in the periplasmic space, as is the case for the glycosulphatase of Prevotella sp. RS2
[41] and MS activities in oral streptococci [33] . It is likely that adhesion to the mucin molecules is a prerequisite for desulphation. Bacterial adherence to CF mucin has been reported for I! aeruginosa and B. cepacia [27, 47] . In addition to cell-bound activities, Streptococcus salivarius and S. gordonii produce extracellular MS activities [48] , and mucin-specific glycosulphatases are found extracellularly in Bact. thetaiotaomicron [ 141, Helicobacter pylori [49] , Ruminococcus torques [50] and BiJidobacterium sp. [50] .
Desulphation increases susceptibility of mucin to degradation by bacterial glycosidases and proteinases [ 131. E? aeruginosa can break down neutral mucins in the sputum of CF patients [lo] . It produces proteinases, some glycosidases [45] and a putative neuraminidase that is active against mucins [51] , although the latter activity may be rare [52] . Desulphation and desialylation of the acidic mucins will increase the amount of the neutral mucin fraction degradable by the organism. In addition, this activity will expose formerly inaccessible oligosaccharides to glycosidases of its own and other infecting bacteria such as S. pneumoniae and Staphylococcus aureus, thus accelerating mucin breakdown.
Desialylation greatly decreases adhesion of I! aeruginosa to CF salivary mucin, not only indicating that sialic acid plays an important role in binding [53] , but also that desialylation may slow further colonisation. Moreover, I! aeruginosa recognises and adheres to type 1 (Galpl-3GlcNAc) and type 2 (Galpl-4GlcNAc) backbone structures of much carbohydrate side chains [26, 28] , which are abundant in tracheobronchial [20, 21] , colonic [19] and salivary [25] mucins. Other neutral oligosaccharide structures, including asialo GM1 and asialo GM2, are recognised by both E? aeruginosa and B. cepacia [28] . The disaccharides GlcNAc/31-3-GalNAc or GlcNAcPl -6-GalNAc found, for example, in core 3 and core 4 mucin oligosaccharide configurations [27] may also be binding receptors for B. cepacia. However, these structures, such as the Galp(l-3)-GlcNAc backbone which is a major site of sulphation of colonic mucins [39, 54] , may be shielded by other carbohydrate residues, sialic acid, or sulphate, and thus not be readily accessible for adhesion. The results of the above studies [26, 28, 531 indicate that various adhesins with different carbohydrate specificities exist on I! aeruginosa. Conflicting data about receptor involvement in the binding of I! aeruginosa to mucin were reported by Sajjan and co-workers [47] . They found that I! aeruginosa bound non-specifically to CF mucin, intestinal mucin, bovine serum albumin, casein and other structurally unrelated proteins by hydrophobic interactions. Partial deglycosylation of mucin may facilitate bacterial colonisation by exposing cryptic binding sites for B. cepacia and possibly I! aeruginosa. Furthermore, the released sugars are likely to promote bacterial growth, including the growth of those that metabolise carbohydrates but do not have glycosidase activities themselves, by analogy with mucin degradation by consortia of oral [15, 161 or colonic [ 17, 181 micro-organisms.
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